Results 1 to 10 of about 954 (199)

A Nanographene‐Porphyrin Hybrid for Near‐Infrared‐Ii Phototheranostics [PDF]

open access: yesAdvanced Science
Photoacoustic imaging (PAI)‐guided photothermal therapy (PTT) in the second near‐infrared (NIR‐II, 1000–1700 nm) window has been attracting attention as a promising cancer theranostic platform.
Hao Zhao   +7 more
doaj   +6 more sources

Small Molecular NIR-II Fluorophores for Cancer Phototheranostics [PDF]

open access: yesInnovation(China), 2021
Summary: Phototheranostics integrates deep-tissue imaging with phototherapy (containing photothermal therapy and photodynamic therapy), holding great promise in early diagnosis and precision treatment of cancers.
Jin-Jun Shao, Xiaochen Dong
exaly   +5 more sources

NIR-II Aggregation-Induced Emission Luminogens for Tumor Phototheranostics [PDF]

open access: yesBiosensors, 2022
As an emerging and powerful material, aggregation-induced emission luminogens (AIEgens), which could simultaneously provide a precise diagnosis and efficient therapeutics, have exhibited significant superiorities in the field of phototheranostics.
Danxia Li, Dong Wang, Ben Zhong Tang
exaly   +5 more sources

Advanced strategic constructions of diketopyrrolopyrrole derivatives‐based organic semiconducting phototheranostics

open access: yesInterdisciplinary Medicine, 2023
Phototheranostics as an advanced approach involved in exogenous light‐mediated diagnosis and treatment techniques has attracted broad attention in interdisciplinary biomedical applications.
Xiaoming Hu, Zhen Yang
exaly   +2 more sources

Conversion therapy strategy: A novel GPC3-targeted multimodal organic phototheranostics platform for mid-late-stage hepatocellular carcinoma [PDF]

open access: yesMaterials Today Bio
Hepatocellular carcinoma (HCC) is typically diagnosed at intermediate to advanced stage, making surgical treatment unfeasible. Conversion therapy aims to reduce tumor stage, improve hepatic resection feasibility, and lower recurrence rates.
Fan Wu   +13 more
doaj   +2 more sources

High-Performance Hybrid Phototheranostics for NIR-IIb Fluorescence Imaging and NIR-II-Excitable Photothermal Therapy [PDF]

open access: yesPharmaceutics, 2023
Photothermal therapy operated in the second near-infrared (NIR-II, 1000–1700 nm) window and fluorescence imaging in the NIR-IIb (1500–1700 nm) region have become the most promising techniques in phototheranostics.
Qi Wang   +8 more
doaj   +2 more sources

Regulating Aggregation‐Induced Emission Luminogen for Multimodal Imaging‐Navigated Synergistic Therapy Involving Anti‐Angiogenesis [PDF]

open access: yesAdvanced Science
As a new avenue for cancer research, phototheranostics has shown inexhaustible and vigorous vitality as it permits real‐time diagnosis and concurrent in situ therapy upon non‐invasive light‐initiation.
Fei Zhang   +11 more
doaj   +2 more sources

Water‐Soluble Aggregation‐Induced Emission Luminogens with Near‐Infrared Emission for Advanced Phototheranostics [PDF]

open access: yesSmall Science, 2023
The development of water‐soluble aggregation‐induced emission luminogens (AIEgens) emitting in the near‐infrared (NIR) window holds promise for efficient biomedical applications.
Hanchen Shen   +9 more
doaj   +2 more sources

Rationally designed NIR-II excitable and endoplasmic reticulum-targeted molecular phototheranostics for imaging-guided enhanced photoimmunotherapy of triple-negative breast cancer [PDF]

open access: yesJournal of Nanobiotechnology
Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer characterized by an extremely poor prognosis. Photoimmunotherapy has emerged as a promising strategy for the treatment of TNBC.
Fen Liu   +9 more
doaj   +2 more sources

Organic small-molecule NIR-II fluorophores for tumor phototheranostics [PDF]

open access: yesLight: Science & Applications
Near-infrared II (NIR-II) fluorophores possess transformative potential for biomedical applications, owing to their deep-tissue penetration, reduced tissue autofluorescence, and low phototoxicity.
Dan Xiang   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy